Who We Are

The New Jersey Life Sciences Vendors Alliance (NJLSVA) is a coalition of businesses, individuals and academia who provide goods and services to New Jersey’s life sciences companies.

The NJLSVA was founded to educate suppliers on trends in industry procurement and public policy that affects the life sciences industry.

Choose NJ’s RFP Watch

Choose New Jersey’s RFP Watch provides up-to-date information on business opportunities throughout the Garden State at a cost that is affordable for all companies – with a place of business in New Jersey – large and small.

To learn more click here

FDA Advises Testing for Zika Virus in All Donated Blood and Blood Components in the U.S.

FDA blueWashington, DC, August 28, 2016 — As a further safety measure against the emerging Zika virus outbreak, the U.S. Food and Drug Administration  (FDA) on Friday issued a revised guidance recommending universal testing of donated Whole Blood and blood components for Zika virus in the U.S. and its territories.

“There is still much uncertainty regarding the nature and extent of Zika virus transmission,” said Peter Marks, M.D., Ph.D., director of the FDA’s Center for Biologics Evaluation and Research.  “At this time, the recommendation for testing the entire blood supply will help ensure that safe blood is available for all individuals who might need transfusion.” Continue reading

BF Business Facilities: 60 Seconds with Choose New Jersey CEO Michele Brown

Michele Brown

Michele Brown

Tinton, NJ, August 27, 2016 — Michele Brown, President and CEO, Choose New Jersey, Inc., sat down with the staff of  BF Business Facilities to discuss incubators, innovation zones, STEM education, incentives and the Garden State in a post-Panamax world.

BF: NJ has established five incubator centers in the state for tech start-ups. Are each of them targeting a different growth sector?

MB: New Jersey is committed to nurturing start-up companies in our key industries and has an extensive network of incubators, accelerators and co-working spaces to support them.

The Commercialization Center for Innovative Technologies (CCIT) is one of the most significant incubation facilities in the U.S. dedicated to life sciences and biotechnology. Located in the heart of New Jersey’s Continue reading

Lenzie Harcum Joins EDA’s Commercialization Center for Innovative Technologies

Lenzie Harcum

Lenzie Harcum

Trenton, NJ, August 26, 2016 — Corey McDonald report in The Star-Ledger/NJ.com that Jersey City resident Lenzie Harcum has joined the state Economic Development Authority (EDA) as the manager of its Commercialization Center for Innovative Technologies (CCIT), the agency announced.

Located between New Jersey’s two research bases — Rutgers and Princeton universities — CCIT is considered one of the most significant incubation facilities in the nation dedicated to life sciences and biotechnology companies.

Harcum will be responsible for all aspects of developing and administering CCIT programming. Continue reading

Event: Save the Date! NJBIA to Host Second Annual Innovation Summit on November 2

Innovation button touch 2Trenton, NJ, August 26, 2016 ― The New Jersey Business & Industry Association (NJBIA) has announced that it will host its Second Annual Innovation Summit on Wednesday, November 2 at the Princeton Plasma Physics Laboratory.

The half day event will bring together thought leaders and feature speakers ranging from successful venture capitalists to internationally recognized CEOs.

This NJBIA Innovation Summit also will highlight the different resources around our state as well as provide insights and networking opportunities with some of the top academic and industry leaders in the defense, life science and the technology industries.

Additional details regarding registration and partnership opportunities will be forthcoming.

 

HHS Says Obamacare Remains Affordable in New Jersey Despite Higher Rates and Fewer Insurers

Obamacare 3Trenton, NJ, August 25, 2016 — Kathleen O’Brien and Jonathan D. Salant report today in The Star-Ledger that increased subsidies should offset the rising cost of Obamacare premiums and allow more than half of New Jerseyans buying insurance through the federal website to pay no more than $75 a month.

That would hold true even if premiums jump by as much as 25 percent, officials of the U.S. Health and Human Services Department said on a conference call Wednesday.

That would be three times greater than the expected average increase of 8 percent by the three companies that sell plans in New Jersey through the federal website established under the Affordable Care Act. Continue reading

EVENT: BioNJ to Host 4th Annual CEO Summit on September 23; BIO CEO Jim Greenwood to Keynote

BioNJ SquareTrenton, NJ, August 25, 2016 ― BioNJ’s 4th Annual CEO Summit, scheduled for Friday, September 23, 2016 at the Bridgewater Marriott, is expected to bring together more than 300 life sciences C-suite leaders and their teams — representing a wide breadth of companies from early to late stage, as well as public, private, revenue and pre-revenue enterprises.

Whether you plan to take your product all the way to market or not, the full-day program will deliver valuable perspectives from industry leaders on how to navigate this dynamic landscape.

BioNJ’s growing list of speakers includes:

  • Mark J. Alles, CEO, Celgene Corporation
  • Robert Goldberg, Ph.D., Vice President & Co-Founder, Center for Medicine in the Public Interest
  • James Greenwood, President & CEO, Biotechnology Innovation Organization (BIO) Continue reading

As Congress Vacations, Clinton Proposes New Federal Fund to Combat Zika Virus

Hillary Clinton nyt black backLaguna Beach, CA, August 24, 2016 — The Associated Press today reports that Hillary Clinton is proposing a new fund to improve the federal government’s response to the continued spread of the Zika vurus.

Clinton says the U.S. is failing to sufficiently invest in public health preparedness, not only for Zika, but health threats from potentially pandemic diseases, climate change and possible bioterrorism.

If elected, Clinton would create what she’s calling a “Public Health Rapid Response Fund” to help federal agencies and local hospital systems respond faster and more aggressively — similarly to how the government responds to a natural disaster. Continue reading

EVENT: Registration Open! HINJ to Host 2016 Life Sciences Celebration October 6; Honorees Announced

Celebration HINJNew Brunswick, NJ, August 24, 2016 ― Please join the HealthCare Institute of New Jersey (HINJ) in honoring meritorious leadership in and contributions to New Jersey’s life sciences community at HINJ’s 2016 Life Sciences Celebration, which will be held Thursday, October 6 from 8:00 to 10:00 a.m. at the Historic Trenton Masonic Temple from 8:00 to 10:00 a.m.

To register for HINJ’s free breakfast event, click here.

HINJ’s 2016 honorees will be:

  • The Honorable Bob Franks Public Service AwardThe Honorable Herb Conaway, Jr., M.D., Member, New Jersey General Assembly, Chair, Health and Senior Services Committee

NIH Reports: Stem Cell Therapy Heals Injured Mouse Brain

NIH in BlueBethesda, MD, August 23, 2016 — The National Institutes of Health (NIH) reported that scientists and clinicians have long dreamed of helping the injured brain repair itself by creating new neurons, and an innovative NIH-funded study published on August 22 in Nature Medicine may bring this goal much closer to reality.

A team of researchers has developed a therapeutic technique that dramatically increases the production of nerve cells in mice with stroke-induced brain damage.

The therapy relies on the combination of two methods that show promise as treatments for stroke-induced neurological injury. The first consists of surgically grafting human neural stem cells into the damaged area, where they mature into neurons and other brain cells. Continue reading

Seton Hall University and Hackensack University Medical Center Move Closer to Medical School’s 2017 Opening

Roche seton and hackensackNutley, NJ, August 23, 2016 — Sara Jerde reports in The Star-Ledger that a medical school that would occupy a former industrial site on the Clifton-Nutley border is one step closer to reality as Nutley officials are preparing to offer it a tax exemption and approve a redevelopment plan, NorthJersey.com reported.

The Hoffmann-La Roche campus was sold in July to an affiliate of Prism Capital Partners. Ahead of the sale, Hackensack University Hospital and Seton Hall University announced their intentions to open the medical school at the former pharmaceutical campus.

Last month, the medical school entered a longterm agreement to rent 16 acres. Financial details were not disclosed.

The medical school, the state’s fifth, is expected to open in the fall of 2017. Continue reading